Skip to main content

Diagnostic options Β· UAE

Therapeutic Drug Monitoring tests in Dubai & UAE

Compare available Therapeutic Drug Monitoring tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

40

Listed price range

550.00–4,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Therapeutic Drug Monitoring test prices

Showing 31–40 of 40 matching tests.

Therapeutic Drug Monitoring diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2850
Oxcarbazepine Metabolite Test

This test measures the concentration of 10-hydroxycarbazepine (MHD), the active metabolite of oxcarbazepine, in a blood sample.

Peripheral Blood (Serum/Plasma) 10 Working Days (Mon–Sat processing) 1,000.00 AED
View
View test specifications and preparation
What it measures
["10-Hydroxycarbazepine (MHD) concentration", "Therapeutic drug exposure"]
Parameters
[{"name": "10-Hydroxycarbazepine (MHD)", "reference_range": "10–35 mg/L (Therapeutic range, may vary based on age, seizure type, renal function)"}]
Preparation
["Collect blood sample immediately before the next scheduled dose (trough level)", "Inform nurse of all medications, including OTC and supplements"]
Indications
["Monitoring therapeutic drug levels in epilepsy patients", "Assessing adherence to oxcarbazepine therapy", "Guiding dose adjustments based on individual metabolism", "Investigating potential drug interactions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 35368-2 ICD-10: R79.8, G40.909
Clinical summary
This test measures the concentration of 10-hydroxycarbazepine (MHD), the active metabolite of oxcarbazepine, in a blood sample.
TEST-2864
Paroxetine Test (Therapeutic Drug Monitoring)

This test measures the concentration of paroxetine in the patient's serum to optimize therapeutic dosing and monitor for potential toxicity.

Serum 2–3 weeks 4,500.00 AED
View
View test specifications and preparation
What it measures
["Paroxetine concentration in serum"]
Parameters
[{"name": "Paroxetine", "reference_range": "20–60 ng/mL"}]
Preparation
["Collect blood sample just before next scheduled dose", "Ensure patient is at steady state (typically 5-7 days after dose change)", "Use red-top tube (no gel separator)", "Separate serum within 2 hours", "Refrigerate or freeze serum until shipment"]
Indications
["Initiation of paroxetine therapy", "Dose adjustments", "Monitoring for toxicity", "Assessing adherence", "Lack of therapeutic response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34891-4 ICD-10: ['Z51.81', 'F32.9', 'F41.9']
Clinical summary
This test measures the concentration of paroxetine in the patient's serum to optimize therapeutic dosing and monitor for potential toxicity.
TEST-2953
Procainamide and N-Acetylprocainamide (NAPA) Test

This test measures the concentration of the antiarrhythmic drug procainamide and its active metabolite NAPA in the blood.

Serum 2–3 Weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["Procainamide", "N-Acetylprocainamide (NAPA)"]
Parameters
[{"name": "Procainamide", "reference_range": null}, {"name": "N-Acetylprocainamide (NAPA)", "reference_range": null}]
Preparation
["Collect sample just before next dose", "Sample must be refrigerated, never frozen"]
Indications
["Therapeutic drug monitoring for procainamide", "Management of ventricular tachycardia", "Assessment of drug efficacy and toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3528-7 ICD-10: Z51.81
Clinical summary
This test measures the concentration of the antiarrhythmic drug procainamide and its active metabolite NAPA in the blood.
TEST-3134
Sirolimus (Rapamycin) Test

This test measures the concentration of sirolimus (rapamycin) in whole blood to guide immunosuppressive therapy.

Whole Blood (EDTA) Same-day reporting when sample arrives by 5 PM 900.00 AED
View
View test specifications and preparation
What it measures
["Sirolimus (Rapamycin) concentration", "Therapeutic drug level"]
Parameters
[{"name": "Sirolimus (Rapamycin) Trough Level", "reference_range": null}]
Preparation
["Fasting is not required.", "Maintain usual medication schedule.", "Avoid taking morning dose until after blood draw.", "Sample must be drawn immediately before next scheduled dose."]
Indications
["Solid organ transplant recipients (kidney, liver, etc.)", "Monitoring therapeutic drug levels", "Dose adjustment guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3395-0 ICD-10: Z51.81
Clinical summary
This test measures the concentration of sirolimus (rapamycin) in whole blood to guide immunosuppressive therapy.
TEST-3225
Tacrolimus (FK506) Therapeutic Drug Monitoring Test

This test measures the concentration of tacrolimus (FK506) in whole blood to guide immunosuppressive therapy in transplant patients.

Whole blood (EDTA) Same-day (sample received by 5 PM) 750.00 AED
View
View test specifications and preparation
What it measures
["Tacrolimus (FK506) concentration", "Therapeutic drug level"]
Parameters
[{"name": "Tacrolimus (FK506)", "reference_range": null}]
Preparation
["Collect sample immediately before the next scheduled dose (trough level).", "Record the exact dosing time and amount."]
Indications
["Post-transplant monitoring", "Dose adjustment guidance", "Assessment of drug efficacy and toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3991-7 ICD-10: Z51.81
Clinical summary
This test measures the concentration of tacrolimus (FK506) in whole blood to guide immunosuppressive therapy in transplant patients.
TEST-3272
Thioridazine Test

This diagnostic test evaluates the concentration of thioridazine in the patient's serum.

Blood (Serum) 14–21 days 1,900.00 AED
View
View test specifications and preparation
What it measures
["Serum thioridazine concentration"]
Parameters
[{"name": "Serum Thioridazine", "reference_range": null}]
Preparation
["No fasting required", "Schedule blood draw just before next dose for trough level", "Complete mandatory consent form (Form 35)", "Note all current medications"]
Indications
["Monitoring patients on long-term thioridazine therapy", "Suspected non-adherence to medication", "Potential drug interactions affecting thioridazine metabolism", "Patients with CYP2D6 polymorphisms", "Assessing therapeutic range"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3948-1 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of thioridazine in the patient's serum.
TEST-3301
Topiramate Test

This diagnostic test evaluates the concentration of topiramate in a patient's serum or plasma.

Serum or Plasma 3–5 business days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Topiramate Concentration"]
Parameters
[{"name": "Topiramate", "reference_range": "5–20 mg/L"}]
Preparation
["Draw blood at peak (2–4 hours post-dose) or trough (0.5–1 hour pre-dose) at steady state.", "Note exact timing and dose.", "No fasting required.", "Use a plain red-top tube (no serum separator gel)."]
Indications
["Dose individualization for epilepsy", "Dose individualization for migraine prevention", "Monitoring therapeutic levels", "Assessing compliance", "Evaluating potential toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10375-9 ICD-10: G40.9
Clinical summary
This diagnostic test evaluates the concentration of topiramate in a patient's serum or plasma.
TEST-3311
Trazodone Therapeutic Drug Monitoring Test

This test measures the concentration of trazodone in the blood to help optimize dosage and monitor for potential toxicity.

Serum 2–3 weeks (after monthly batch cutoff) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Serum Trazodone Concentration"]
Parameters
[{"name": "Trazodone", "reference_range": "0.5–2.5 mg/L (therapeutic window)"}]
Preparation
["Inform doctor of all medications", "No special fasting required"]
Indications
["Initiating trazodone therapy", "After dose changes", "Appearance of adverse effects", "Suspected non-adherence"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 35729-1 ICD-10: Z51.81
Clinical summary
This test measures the concentration of trazodone in the blood to help optimize dosage and monitor for potential toxicity.
TEST-3337
Trimipramine Therapeutic Drug Monitoring Test

This diagnostic test evaluates the concentration of trimipramine in the patient's serum to guide safe and effective dosing.

Serum 2–3 weeks 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Trimipramine Concentration"]
Parameters
[{"name": "Trimipramine", "reference_range": "0.1 ng/mL (LOD)"}]
Preparation
["Hold morning dose", "Take medication after blood draw", "Resume normal schedule unless instructed otherwise"]
Indications
["Monitoring therapeutic levels", "Assessing adherence", "Guiding dose adjustments", "Investigating suspected toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3949-0 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of trimipramine in the patient's serum to guide safe and effective dosing.
TEST-3373
Vancomycin Test (Therapeutic Drug Monitoring)

This test measures the lowest concentration of vancomycin in the blood just before the next dose (trough level). It helps optimize dosing to ensure effectiveness and minimize toxic...

Serum Same Day (sample received by 4 PM) 900.00 AED
View
View test specifications and preparation
What it measures
["Vancomycin serum concentration", "Trough level"]
Parameters
[{"name": "Vancomycin", "reference_range": "10–20 mg/L"}]
Preparation
["No fasting required", "Sample must be collected exactly 30 minutes before the next scheduled vancomycin infusion"]
Indications
["Monitoring vancomycin therapy", "Suspected vancomycin toxicity", "Adjusting vancomycin dosage"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 4103-0 ICD-10: Z51.81, Z16.21, T36.8X5A
Clinical summary
This test measures the lowest concentration of vancomycin in the blood just before the next dose (trough level). It helps optimize dosing to ensure effectiveness and minimize toxicity.

Category overview

Therapeutic Drug Monitoring: overview

Managing chronic conditions with specialized medications requires a delicate balance, and precise biological monitoring ensures your treatment remains safe and effective. Within our comprehensive Biochemistry services, Therapeutic Drug Monitoring measures the exact concentration of specific prescription medications in your bloodstream. By utilizing state-of-the-art diagnostic technology, this vital clinical testing provides your healthcare provider with the critical data needed to optimize dosing, prevent toxicity, and safely guide your personalized medical care. Widely respected for clinical excellence among diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, unparalleled analytical accuracy, and highly efficient reporting for sensitive treatments. Take control of your medication managementβ€”schedule your therapeutic drug monitoring in UAE, book a seamless home sample collection, or consult our dedicated medical experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.